🔎 Trials Near Me

Utama › Kanser Metastatik › Missouri › Kansas City

Kajian klinikal Kanser Metastatik di Kansas City, MO

15 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • St. Lukes Hospital of Kansas City, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • University of Kansas Medical Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05382559

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Mengambil pesertaFasa 1
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05803382

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Kansas Medical Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05875168

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Mengambil pesertaFasa 2/3
  • Premier Imaging, Kansas City
  • St. Joseph Medical Center, Kansas City
  • MidAmerica Cancer Care - American Oncology Partners, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06989437

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Mengambil pesertaFasa 1
  • The University of Kansas Medical Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06915753

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Mengambil pesertaFasa 3
  • HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mengambil pesertaFasa 3
  • Saint Luke's Cancer Institute, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • The University of Kansas Cancer Center - Westwood, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Mengambil pesertaFasa 1/2
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT05691491

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Mengambil pesertaFasa 3
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Cancer Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06216301

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Mengambil pesertaFasa 3
  • Saint Luke's Cancer Institute, Kansas City
  • The University of Kansas Cancer Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT06757634

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Mengambil pesertaFasa 2/3
  • MidAmerica Cancer Care, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT06697301

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • University of Kansas Cancer Center, Westwood · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06064877

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Kansas City
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Metastatik di bandar lain

Kajian lain di Kansas City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.